Literature DB >> 11926855

Risk of hepatitis C virus transmission from an infected gynecologist to patients: results of a 7-year retrospective investigation.

R Stefan Ross1, Sergei Viazov, Marion Thormählen, Lutz Bartz, Jana Tamm, Peter Rautenberg, Michael Roggendorf, Arno Deister.   

Abstract

BACKGROUND: Currently, it is not known how often hepatitis C virus (HCV) is transmitted from infected health care workers to patients during medical care. In the present investigation, we tried to determine the rate of provider-to-patient transmission of HCV among former patients of an HCV-positive gynecologist after it was proven that he infected one of his patients with HCV during a cesarean section.
METHODS: All 2907 women who had been operated on by the HCV-positive gynecologist between July 1993 and March 2000 were notified about potential exposure and were offered free counseling and testing. The crucial differentiation between HCV transmissions caused by the gynecologist and infections contracted from other sources was achieved by epidemiological investigations, nucleotide sequencing, and phylogenetic analysis.
RESULTS: Of the 2907 women affected, 78.6% could be screened for markers of HCV infection. Seven of these former patients were found to have HCV. Phylogenetic analysis of HCV sequences from the gynecologist and the women did not indicate that the virus strains were linked. Therefore, no further iatrogenic HCV infections caused by the gynecologist could be detected. The resulting overall HCV transmission rate was 0.04% (1 per 2286; 95% confidence interval, 0.008%-0.25%).
CONCLUSION: To our knowledge, this is the largest retrospective investigation of the risk of provider-to-patient transmission of HCV conducted so far. Our findings support the notion that such transmissions are relatively rare events and might provide a basis for future recommendations on the management of HCV-infected health care workers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11926855     DOI: 10.1001/archinte.162.7.805

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Nosocomial transmission of bloodborne viruses from infected health care workers to patients.

Authors:  B Lynn Johnston; John M Conley
Journal:  Can J Infect Dis       Date:  2003-07

2.  Effect of bottlenecking on evolution of the nonstructural protein 3 gene of hepatitis C virus during sexually transmitted acute resolving infection.

Authors:  Josep Quer; Juan Ignacio Esteban; Joan Cos; Sílvia Sauleda; Laura Ocaña; María Martell; Teresa Otero; Maria Cubero; Eduard Palou; Pedro Murillo; Rafael Esteban; Jaume Guàrdia
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Canadian hepatitis C look-back investigation to detect transmission from an infected general surgeon.

Authors:  Meenakshi Dawar; Tammy L Stuart; Lamont E Sweet; Anne M Neatby; Lewis P Abbott; Anton P Andonov; Tom Wong; Robert Gervais; Rob Stirling
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 4.  Health care-associated hepatitis C virus infection.

Authors:  Bruno Pozzetto; Meriam Memmi; Olivier Garraud; Xavier Roblin; Philippe Berthelot
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

5.  Epidemiological profiles of human immunodeficiency virus and hepatitis C virus infections in Malian women: Risk factors and relevance of disparities.

Authors:  Nouhoum Bouare; Andre Gothot; Jean Delwaide; Sebastien Bontems; Dolores Vaira; Laurence Seidel; Paul Gerard; Christiane Gerard
Journal:  World J Hepatol       Date:  2013-04-27

Review 6.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

7.  Temporal variations in the hepatitis C virus intrahost population during chronic infection.

Authors:  Sumathi Ramachandran; David S Campo; Zoya E Dimitrova; Guo-liang Xia; Michael A Purdy; Yury E Khudyakov
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.